[OPNT] YoY Quarter Result on 31-Oct-2017 [#Q3]

Stock
[OPNT] Opiant Pharmaceuticals, Inc.
Announcement Date
04-Dec-2017
Financial Year
2017
Quarter
31-Oct-2017 [#Q3]
Profit Trend
QoQ- -1,561.65%
YoY- -837.27%
Quarter Report
OPNT's Result
OPNT's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
Revenue 8,601 20,494 4,248 22 1,121 120 0 -
PBT 725 10,684 -918 -5,633 -601 -11,110 -775 -
Tax -6 -24 -20 -34 -19 2 1 -
NP 725 10,684 -918 -5,633 -601 -11,110 -775 -
Tax Rate 0.85% 0.22% - - - - - -
Total Cost 7,876 9,810 5,166 5,655 1,722 11,230 775 47.94%
Ratio Analysis
30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
NP Margin 8.43 52.13 -21.61 -25,604.55 -53.57 -9,258.35 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
EPS 0.17 2.64 -0.32 -2.77 -0.30 -6.00 -0.43 -
EPS Diluted 0.15 1.97 -0.32 -2.77 -0.30 -6.00 -0.43 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.